I've analyzed the stock in more detail and have summarized my findings here:
1. Moat: 8/10
- Strong brands, massive advertising and sales power, high repurchase rate. That’s a real moat.
- Risks include private labels, price-conscious shoppers, and weakness in North America. Organic growth in 2026 came entirely from prices (+1%); volume remained flat. So pricing power appears to be waning.
- That’s why I’m giving it an 8 instead of a 9–10.
2. Financials: 6/10
- Margins are excellent: EBIT margin approx. 23.5%, net margin approx. 18.4% (from your slide). However, the gross margin is declining, from 51.2% to 50.2%.
- Growth is weak: 2027 forecast: organic growth of +1–3%, core EPS of $6.89–7.11 (0–3% growth). The estimates in the chart show revenue of +2.1%/+3.0%/+3.2% and earnings of +2.5%/+6.9%/+4.3% for 2027–29.
- Added to this is a headwind of $1 billion due to higher costs, primarily for oil-based raw materials.
- The margins are in line, but P&G is not currently delivering “impressive growth.”
3. Valuation: Fair to slightly expensive
- The P/E ratio (NTM) of 22.3x is below the median of 23.3x and the 5-year average of 24.9x. However, growth has slowed, so the discount is justified and does not represent a bargain.
- PEG 4.46 is above its own average of 4.14. That is high for a company with 2–3% profit growth.
- EV/Sales of 4.4x compared to an average of 4.6x.
- The average analyst price target of $161.65 offers only about 2.5% upside potential.
4. Balance Sheet: Solid, but Without a Buffer
- Total debt: $34.1 billion; cash: $9.9 billion; net debt: $24.2 billion. This corresponds to approximately 1.0x EBITDA, and the interest coverage ratio is about 45x.
- Noteworthy: The company plans to pay approximately $10 billion in dividends plus $5 billion in share buybacks. This exceeds free cash flow, which stood at $14.0 billion in fiscal year 2025. The difference is financed through debt, and interest expenses are projected to rise from $447 million to $611 million, according to the chart.
- Not a disqualifying factor, but a warning sign.
Conclusion: HOLD
A high-quality company with a strong moat, but lacking growth and no longer undervalued. It lacks the growth needed for an “Overweight” rating, but the quality is too good for a “Sell” rating.
Judging by the results, it wouldn’t be a buy right now, but I have it in my portfolio and am even considering selling it because I think there are significantly better companies out there.
Does the crowd think the same way, or am I missing something here?

